The new survivors and a new era for trauma research
Karim Brohi and Martin Schreiber, Guest Editors of the Special Issue on Trauma, describe a new era in exploration of the biology of injury response and translation of new opportunities into clinical practice.
Vyšlo v časopise:
The new survivors and a new era for trauma research. PLoS Med 14(7): e32767. doi:10.1371/journal.pmed.1002354
Kategorie:
Editorial
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002354
Souhrn
Karim Brohi and Martin Schreiber, Guest Editors of the Special Issue on Trauma, describe a new era in exploration of the biology of injury response and translation of new opportunities into clinical practice.
Zdroje
1. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, et al. CONTROL Study Group. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma. 2010;69:489–500. doi: 10.1097/TA.0b013e3181edf36e 20838118.
2. Holcomb JB. Major scientific lessons learned in the trauma field over the last two decades. PLoS Med. 2017 Jul.
3. Resuscitation Outcomes Consortium. https://roc.uwctc.org/. Accessed: 31 May 2017.
4. International Trauma Research Network. http://www.intrn.org. Accessed: 31 May 2017.
5. Inflammation and the Host Response to Injury. http://www.gluegrant.org. Accessed 31 May 2017.
6. Hess JR, Brohi K, Dutton RP, Hauser CJ, Holcomb JB, Kluger Y, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008 Oct;65(4):748–54. doi: 10.1097/TA.0b013e3181877a9c 18849786.
7. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307–10. doi: 10.1097/TA.0b013e3180324124 17297317.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2017 Číslo 7
- Jak rozpoznat pacienty s familiární hypercholesterolémií ve své praxi
- Myasthenia gravis: kombinace chirurgie a farmakoterapie jako nejefektivnější modalita?
- Statinová intolerance
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Mutace v genu PCSK9 zodpovědné za rozvoj familiární hypercholesterolémie
Najčítanejšie v tomto čísle
- Signatures of inflammation and impending multiple organ dysfunction in the hyperacute phase of trauma: A prospective cohort study
- Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines
- Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29
- Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models